Clinician Outreach and Communication Activity (COCA)
COCA prepares clinicians to respond to emerging health threats and public health emergencies by communicating relevant, timely information related to disease outbreaks, disasters, terrorism events, and other health alerts.
Learn more about COCA
- COCA Call: May 19, 2022: Clinical Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
- COCA Call: May 5, 2022: Evaluating and Supporting Patients Presenting with Cognitive Symptoms Following COVID
- COCA Now: April 4, 2022: New COVID-19 Test to Treat Initiative and Locator Tool
- COCA Now: March 25, 2022: New CDC COVID-19 Quarantine and Isolation (Q&I) Calculator
- COCA Now: February 24, 2022: Updated List of High-Risk Medical Conditions for Severe COVID-19 Outcomes
- COCA Call: February 24, 2022: Updated Guidance for Clinicians on COVID-19 Vaccines
- COCA Call: February 10, 2022: COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children
- COCA Now: February 01, 2022: Ivermectin Products are Not Approved by FDA to Prevent or Treat COVID-19
- COCA Now: January 31, 2022: How to Talk with Parents and Caregivers about COVID-19 Vaccination
- COCA Call: January 13, 2022: Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings
- COCA Call: January 12, 2022: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19
- COCA Now: December 22, 2021: CDC Encourages Healthcare Providers to Recommend COVID-19 Self-testing Before Holiday Gatherings
- COCA Call: December 17, 2021: Updated Guidance for Clinicians on COVID-19 Vaccines
- COCA Call: December 9, 2021: Molecular Approaches for Clinical and Public Health Applications to Detect Influenza and SARS-CoV-2 Viruses
- COCA Call: November 18, 2021: What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19
- COCA Call: November 4, 2021: Pediatric COVID-19 Vaccines: CDC’s Recommendations for Pfizer-BioNTech COVID-19 Vaccine Primary Series in Children 5–11 Years Old
- COCA Now: November 2, 2021: CDC Updates Blood Lead Reference Value to 3.5 µg/dL
- COCA Call: October 26, 2021: What Clinicians Need to Know about the Recent Updates to CDC’s Recommendations for COVID-19 Boosters
- COCA Call: October 7, 2021: 2021–2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners
- COCA Call: September 30, 2021: Evaluating and Supporting Patients Presenting With Fatigue Following COVID-19
- COCA Call: September 28, 2021: What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination
- COCA Now: September 15, 2021: COCA NOW Clarification COCA Memo: Monoclonal Antibodies Bamlanivimab and Etesevimab May Be Less Effective for Treating Cases of COVID-19 Caused by SARS-CoV-2 Variants
- COCA Call: September 9, 2021: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines
Learn about emergency preparedness and response activities and current public health threats.
Earn free CME, CNE, CPH, ACPE, CEU, CECH, and AAVSB/RACE continuing education.
Get new & updated guidance on natural disasters, infectious diseases, and other public health hazards.
Find information on upcoming training and conference opportunities from federal agencies or COCA Partners.
Find emergency preparedness and response training resources created specifically for clinicians.
Get emails about upcoming COCA Calls, training resources, and other public health updates.
COCA partners with national medical and public health organizations to ensure that clinicians have timely, credible, and accurate information needed to provide care.
List of COCA Partners
CDC’s Epidemic Information Exchange (Epi-X) is a secure, web-based network that serves as a powerful information exchange. It connects public health professionals involved in identifying, investigating, and responding to public health threats.